Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |